SYS6010 Versus Chemotherapy in Locally Advanced or Metastatic/Recurrent Esophageal Squamous Cell Carcinoma

NCT07417735 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

436

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced/Metastatic/Recurrent ESCC

Interventions

DRUG: SYS6010
DRUG: Investigator's Choice of Chemotherapy (Irinotecan hydrochloride，Paclitaxel，Docetaxel)

Sponsor

CSPC Megalith Biopharmaceutical Co.,Ltd.